Pharma & Biotech

A small biotechnology company is capturing significant market attention as industry experts identify substantial growth potential in its innovative cancer...

The biotechnology sector was rattled by an unexpected development yesterday. In a move that caught investors off guard, Goldman Sachs...

After a period of underperformance, Cellectar Biosciences shares are displaying initial signs of recovery. This comes at a time when...

The battle for dominance in the lucrative weight-loss medication sector has entered a critical new phase. Pharmaceutical giant Pfizer has...

Investor attention is firmly fixed on Assembly Biosciences as the biotechnology firm prepares to release its third-quarter financial results. Following...

Thermo Fisher Scientific, a global leader in life sciences, has announced a transformative $8.9 billion acquisition that underscores its ambitious...

The proposed acquisition of CureVac by BioNTech is accelerating toward its final stages. CureVac investors face a pivotal decision on...

Investors in the Mainz-based biotechnology firm BioNTech received an unexpected financial update, as the company dramatically revised its annual revenue...

Beam Therapeutics Inc enters a potentially transformative period this week, with two significant events poised to influence the biotechnology firm's...

Legend Biotech Corp finds itself at a critical juncture, navigating a complex landscape of promising clinical developments against a backdrop...